​Søren Henningsen, board member, entrepreneur and chairman, Denmark
Co-founder of Salient Pharma and 1937 ApS. Chairman of the board of CAP CPH, Board member of IDFG Denmark Limited. Søren Henningsen holds an MSc in economics from the University of Copenhagen. He was previously employed with PA Consulting Group and subsequently with Dream Investment Company. Since then, he has worked with corporate acquisitions in LaCorp Capital Partners and as a partner at Deltaq Private Equity (listed on NASDAQ OMX) and as such brings an extensive experience in investment activities from the Private Equity world. In later years he has made a turnaround of HB Medical as a COO and sold the company to a professional investor.

​

A company run by Senior Executives
With a significant international track record

Proven results

  • Shareholder value creation in excess of EUR 1 billion
  • Investment management over EUR 10 billion
  • 80+ Mergers & Acquisitions and integrations
  • Over 100 years of operational leadership experience
  • IPO listing, Management Buy Out, PE co-ownership
  • Numerous Management and Advisory Boards

Deep competencies

  • Healthcare and pharmaceuticals
  • Food ingredients
  • Furniture
  • Clean technology, renewables and energy efficiency
  • Smart home, smart city
  • A/V and electronics
  • Transportation and related Technologies
  • Industrial production technologies
  • Industrial Investment and portfolio management
  • SaaS and other business models